NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/15/2022
Back to search
Official data from USPTO
EXELA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
11/15/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 35, 40, 42
Filing date
06/24/2021
Registration date
11/15/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2022
Last transaction
11/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2016-00-00
First use in commerce
2016-00-00
Drawing code
5
Owner type
03
Owner location
Lenoir, NC, US
Examiner
DUENAS, TAYLOR
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "EXELA" in blue with the "X" in blue, yellow, orange, and white.
Holders and representatives
Holders
Exela Holdings, Inc.
Representatives
Laura M. Konkel MICHAEL BEST & FRIEDRICH LLP
Technical classification
Nice Classes
Class 5Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark for pharmaceuticals for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctionhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonalpsychiatricimmune system diseases and disordersexcluding pharmaceuticals that are directly targeted for the treatment of cancer
Class 35
Marketing services
Class 40
Manufacture of pharmaceutical products for others
Class 42
Pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/30/2022
PUBO
PUBLISHED FOR OPPOSITION
08/30/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2022
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
04/19/2022
GPRA
PRIORITY ACTION E-MAILED
04/19/2022
CPRA
PRIORITY ACTION WRITTEN
04/19/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/12/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2022
DOCK
ASSIGNED TO EXAMINER
03/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2021
NWAP
NEW APPLICATION ENTERED
06/28/2021
Continuous trademark protection
Get notified about every new filing that threatens EXELA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.